KSCM
IBB icon

Kamunting Street Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Kamunting Street Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,000
Closed -$1.09M – 51
2019
Q2 		$1.09M Buy
+10,000
New +$1.06M 1.07% 20

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
N
Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Kamunting Street Capital Management's IBB Position: Q3 2019 in Review

Kamunting Street Capital Management sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 10,000 shares — an estimated $1.09M sold.

Kamunting Street Capital Management first reported a position in IBB in Q2 2019 and held it in 1 quarter. The position peaked at $1.09M in Q2 2019. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

  • Kamunting Street Capital Management reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
  • Kamunting Street Capital Management sold 10,000 iShares Biotechnology ETF shares in Q3 2019, an estimated $1.09M.
  • Kamunting Street Capital Management first reported a position in iShares Biotechnology ETF in Q2 2019 and held it in 1 quarter.
  • Kamunting Street Capital Management's iShares Biotechnology ETF position peaked at $1.09M in Q2 2019.
  • 597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Kamunting Street Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.